Article

GCKR genetic variants and circulating FGF21 define a metabolic risk signature in Metabolic-associated Steatotic Liver disease

2026-02-09

Abstract excerpt

<title>Abstract</title> <p> <bold>Background & Aims:</bold> Metabolic dysfunction–associated steatotic liver disease (MASLD) represents a broad clinicopathological spectrum, extending from isolated hepatic steatosis to its progressive inflammatory stage, metabolic dysfunction–associated steatohepatitis (MASH). Interindividual variability in disease onset and progression reflects a complex interplay between meta...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9e9f73ce-7300-56c6-aeb0-f40f38ea0f9f
DOI: 10.21203/rs.3.rs-8643484/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

GCKR genetic variants and circulating FGF21 define a metabolic risk signature in Metabolic-associated Steatotic Liver diseaseDOI 10.21203/rs.3.rs-8643484/v1Read

GCKR genetic variants and circulating FGF21 identify a metabolic risk signature in metabolic dysfunction-associated steatotic liver disease.Semantic proximity Read

Human genetics of steatotic liver disease: insights into insulin resistance and lipid metabolism.Semantic proximity Read

Unraveling Mechanisms of Genetic Risks in Metabolic Dysfunction-Associated Steatotic Liver Diseases: A Pathway to Precision Medicine.Semantic proximity Read

Genetics of Metabolic Dysfunction-associated Steatotic Liver Disease: The State of the Art Update.Semantic proximity Read

Are we ready for genetic testing in metabolic dysfunction-associated steatotic liver disease?Semantic proximity Read

Polygenic risk score of metabolic dysfunction-associated steatotic liver disease amplifies the health impact on severe liver disease and metabolism-related outcomes.Semantic proximity Read

Genetic Risk Factors for Metabolic Dysfunction-Associated Steatotic Liver Disease.Semantic proximity Read

Genomic Signatures of MASLD: How Genomics Is Redefining Our Understanding of Metabolic Liver DiseaseSemantic proximity Read

Early Insights from Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Patients: An Observational Study on Polygenic Risk and Liver BiomarkersSemantic proximity Read

Mapping the genomic landscape of MASLD: A framework for molecular subtyping and precision hepatology.Semantic proximity Read

Recent advances in MASLD genetics: Insights into disease mechanisms and the next frontiers in clinical applicationSemantic proximity Read

Polymorphisms Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease Influence the Progression of End-Stage Liver DiseaseSemantic proximity Read